Dede Willams
Oxea Puts US Intermediates Customers on Allocation
The intermediates business of US-based Oxea Corporation has put all customers on allocation, due to technical issues arising from a scheduled maintenance turn-around at its Bay City, Texas, facility.
Lilly Deutschland GmbH
Nouryon
GlaxoSmithKline (GSK) plc
Sanofi S.A.
Novartis International AG
Solvay
European Chemical Industry Council - Cefic aisbl
VCI - German Chemical Industry Association
Merck KGaA
Saltigo GmbH
Oxea
Dow Chemical Company
Songwon International AG
Dystar
Bachem
Covestro
Deloitte GmbH Wirtschaftsprüfungsgesellschaft
Ineos
WeylChem International GmbH
CheMondis GmbH
Cambrex Corporation
AstraZeneca
EDB Singapore
Lenzing AG
Brenntag SE
Merck & Co
Ineos
Alfred Talke GmbH & Co. KG
LANXESS Deutschland GmbH
Yara International ASA
Lonza AG































